Chelyabinsk Regional Clinical Skin and Venereal Dispensary

Chelyabinsk 454092

0 studies enrolling now · 2 studies all time

What they study most

Psoriasis

Studies at this site

• A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed
• Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed